Neuroprotective Natural Products

Clinical Aspects and Mode of Action
 
 
Wiley-VCH (Verlag)
  • erschienen am 1. März 2017
  • |
  • XXVI, 346 Seiten
 
E-Book | ePUB mit Adobe-DRM | Systemvoraussetzungen
978-3-527-80380-4 (ISBN)
 
Focusing on the molecular mechanisms of powerful naturally occurring agents and their implication for drug discovery, this timely book presents an overview of the most recent research advances in the field of bioactive natural products and natural drug formulations to combat today's destructive diseases.
To this extent, the authors discuss the most severe neurological disorders in our modern civilization, such as Alzheimer's, Parkinson's and Huntington's disease, as well as ischemic brain stroke and depression. The emerging diversity of active compounds is covered in detail, including flavonoids, cannabinoids and oleanolic acid, while experts in the field explain the chemistry, mode of action and clinical aspects of novel neuroprotective natural products. In each case, the benefits of treatments using natural products are addressed from the perspective of modern as well as traditional medicine.
With its multidisciplinary viewpoint, this is the ideal companion for medicinal and natural products chemists as well as neuroscientists, biochemists, pharmacologists, neurobiologists, and phytotherapists.
1. Auflage
  • Englisch
  • Weinheim
  • |
  • Deutschland
  • 46
  • |
  • 9 farbige Abbildungen, 46 s/w Abbildungen
  • 5,00 MB
978-3-527-80380-4 (9783527803804)
weitere Ausgaben werden ermittelt
After receiving his Ph.D. in 1997 at Visva-Bharati University (India), Goutam Brahmachari joined his alma mater and currently holds the position of a full professor of chemistry since 2011. Research interests of his group include green chemistry, organic synthesis and medicinal chemistry of natural products, as well as artificial compounds. With more than 18 years of experience in both teaching and research, he has produced nearly 160 scientific publications including original research papers, review articles, books and invited book chapters in the fields of natural products and green chemistry. He has authored/edited 18 books and more than 30 book chapters so far published by internationally reputed major presses. He is the Series Editor of the Book Series 'Natural Product Drug Discovery'.
Neuroprotective natural products: An overview

Neuroprotective agents: An overview on the general modes of action

Beneficial upshots of naturally occurring antioxidant compounds against neurological disorders

Natural neuroprotectives for the management of Parkinson's Disease

Neuroprotective effect of Ayurvedic preparations and natural products on Parkinson's disease

Lipid peroxidation and mitochondrial dysfunction in Alzheimer's and Parkinson's diseases: Role of natural products as cytoprotective agents

Anti-Alzheimer's agents from sea

Natural products against Huntington's disease: Implications of neurotoxic animal models and trangenics in preclinical studies

Possible role of neuroprotectants and natural products in epilepsy: Clinical aspects and mode of action

Neuroprotective effects of flavonoids in epilepsy

The role of noncompetitive antagonists of the N-methyl-D-aspartate (NMDA) receptors in treatment-resistant depression

Safety and efficacy of Ashwagandha (Withania somnifera)

Cannabinoids: A group of promising neuroprotective agents

Chapter 1
Neuroprotective Natural Products: Clinical Aspects and Modes of Action - An Overview


Goutam Brahmachari

Visva-Bharati (a Central University), Department of Chemistry, Laboratory of Natural Products and Organic Synthesis, Santiniketan, West Bengal, 731 235, India

1.1 Introduction


The book titled Neuroprotective Natural Products: Clinical Aspects and Modes of Action is an endeavor to the present cutting-edge research in the neuroprotective natural products and helps the reader understand how natural product research continues to make significant contributions in the discovery and development of new medicinal entities. The reference is meant for phytochemists, synthetic chemists, combinatorial chemists, biologists, pharmacologists, clinicians, as well as other practitioners and advanced students in related fields. This book, comprising 12 technical chapters, highlights the clinical aspects and modes of action of potential neuroprotective natural products with an intention to unravel their pharmaceutical applicability in modern drug discovery processes in the field of neurodegenerative diseases.

This introductory chapter presents an overview of the book and summarizes the contents and subject matter of each chapter so as to offer certain glimpses of the coverage of discussion to the readers before they go for detailed study.

1.2 An Overview of the Book


This book contains a total of 12 technical chapters - Chapters 2-13; this section summarizes the contents and subject matter of each of these chapters.

1.2.1 Chapter 2


In Chapter 2, Volsko and Dutta have offered an overview on the general modes of action of neuroprotective agents in several neurodegenerative disorders as studied in various animal models. The results suggest that administration of such therapeutic candidates postpones disease progression and increases survival rate. Neuroprotective agents act through certain key pathways associated with development, maturation, and repair in abnormal pathological environments during neurodegenerative diseases, thereby resulting in the reduction of cellular distress and slowing disease development in the nervous system. Specific trophic factors, polypeptides, and heterodimers activate or block the receptors during pathogenesis to slow disease progression. Natural neuroprotective agents that are effective in humans and suppress symptoms and delay disease progression are regarded as promising lead candidates in the drug discovery process in treating neurodegenerative diseases. Modifying treatments based on neuropathology of each such disease is essential, and this chapter boosts the ongoing research in this remarkable field.

1.2.2 Chapter 3


Sil and his group have furnished a thorough discussion on the beneficial effects of different classes of naturally occurring antioxidant compounds against various neurological disorders in Chapter 3. Oxidative stress (elevation of intracellular reactive oxygen species level) is a major cause in the development and progression of neurological diseases such as neurodegenerative diseases, movement disorders, and so on. The brain in particular is prone to this oxidative stress phenomenon, and impairment in memory and cognition are hallmarks of progressive neurodegenerative diseases. Therefore, targeting these diseases with antioxidants may be expected to be a fruitful solution. Antioxidant molecules combat oxidative stress by neutralizing excessively produced free radicals and inhibiting them from initiating the signaling cascades and chain reactions that result in various diseases and premature aging. Several natural compounds with antioxidant property have been found to be greatly effective in treating these diseases as they effectively scavenged free radicals and inhibited their generation. This chapter covers the sources of such antioxidants and the general mechanism by which they play a protective role in different cognitive and movement-related neurological disorders. This illuminating review on natural antioxidants would obviously enrich the readers and would motivate them in undertaking in-depth further research.

1.2.3 Chapter 4


Chapter 4 is dedicated to natural neuroprotectives for the management of Parkinson's disease (PD) by Ali and his group. PD is regarded as the second most general neurodegenerative disorder that involves a decreased nigrostriatal availability of dopamine, resulting in motor impairment including bradykinesia, rigidity, and tremor. Currently, the exact cause of this devastating disease is unclear with no single factor accountable for neurodegeneration. It shows that several factors may contribute to its development, such as formation of reactive oxygen species (ROS), protein misfolding, and neuroinflammation. The deficiency of dopamine occurs due to loss of dopaminergic neurons and degradation of dopamine. It has been evidenced that oxidative stress is critically involved in the pathogenesis of PD, and thus antioxidants may find beneficial role in treating the disease. This chapter deals with the literature covering the use of various natural antioxidative neuroprotective agents including naringenin, curcumin, vitamin E, vitamin C, resveratrol, coenzyme Q10, and melatonin, which may find application in PD. In addition, the authors have discussed on the mechanism of actions and in vitro and in vivo application of natural neuroprotectives in experimental animal models and in patients with PD. This chapter offers an up-to-date development in this field.

1.2.4 Chapter 5


In Chapter 5, Borah and his group have discussed the role and therapeutic efficacy of Ayurvedic preparations in treating Parkinson's disease (PD). A prospective clinical trial on the effectiveness of an Ayurvedic formulation, composed of Mucuna pruriens, Withania somnifera, Hyoscyamus niger, and Sida cordifolia, on PD patients demonstrated significant improvement of the symptoms. The authors have elaborated the potentials of such natural products used in Ayurvedic formulations as alternative/adjuvant to the dopamine replenishment therapy for PD and also highlighted their molecular mechanisms of action.

1.2.5 Chapter 6


Chapter 6 deals with the role of natural products as cytoprotective agents against lipid peroxidation and mitochondrial dysfunction in Alzheimer's and Parkinson's diseases by Gómez-Serranillos and her group. Among their pathological hallmarks, increased lipid peroxidation and mitochondrial dysfunction appear to be relevant from the early events of these age-related disorders. Neurodegenerative diseases in humans are strongly associated with oxidative stress generated by ROS, which can cause oxidative damage to cell structures, including alterations in membrane lipids, proteins, and DNA. In turn, it may trigger cellular organelle dysfunction that finally leads to cell death. Lipid peroxidation is a process that takes place along the cell membrane by effect of free radical oxidation of polyunsaturated fatty acids, and as a consequence of this chain reaction, it results in the formation of reactive products with toxic effects. Mitochondria are cytoplasmic organelles that regulate both metabolic and apoptotic signaling pathways, including energy generation; thus, they exhibit special susceptibility to oxidative stress, which eventually provokes the mitochondrial dysregulation. Herein, the authors have provided a detailed overview of the involvement of lipid peroxidation and mitochondrial dysfunction in Parkinson's and Alzheimer's diseases, with special consideration to natural products exerting beneficial effects on neurodegeneration models through an amelioration of these molecular disorders.

1.2.6 Chapter 7


Dev and Maurya have presented an exhaustive review on potential marine-derived anti-Alzheimer's agents in Chapter 7. Marine secondary metabolites develop under very adverse conditions and, thus, may contain very unusual structural skeletons; such chemical entities with new and varying scaffolds and interesting biological activity have created a new hope of drug discovery and development for various disease areas including neurodegenerative disorders. The main hurdle in drug discovery for Alzheimer's disease is associated with the permeability of blood-brain barrier (BBB) to exhibit drug's effective activity. A number of marine natural products and their synthetic analogs showed efficacy with good bioavailability against Alzheimer's disease. This chapter includes 163 compounds and some extracts from different marine sources such as algae, sponges, coelenterates, bryozoans, molluscs, tunicates, and echinoderms together with their pharmacological activity in the treatment of Alzheimer's disease. This informative review would act as a stimulus in this direction.

1.2.7 Chapter 8


Huntington's disease (HD) is a neurological disorder characterized by abnormal body movements (chorea) associated with cognitive and motor dysfunctions, neuropsychiatric disturbances, and striatal damage. Therapeutic advancement in screening of natural products against HD suffers from constraints such as limited animal models and giving maximum emphasis on cellular models during experimentations. However, recent progress in animal HD transgenic models expressing mutant proteins may reveal the therapeutic efficacy of natural products against HD, a disease with less elucidated pathogenesis and inadequate treatment strategies. In Chapter 8, Dey has offered an illuminating and...

Dateiformat: ePUB
Kopierschutz: Adobe-DRM (Digital Rights Management)

Systemvoraussetzungen:

Computer (Windows; MacOS X; Linux): Installieren Sie bereits vor dem Download die kostenlose Software Adobe Digital Editions (siehe E-Book Hilfe).

Tablet/Smartphone (Android; iOS): Installieren Sie bereits vor dem Download die kostenlose App Adobe Digital Editions (siehe E-Book Hilfe).

E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nicht Kindle)

Das Dateiformat ePUB ist sehr gut für Romane und Sachbücher geeignet - also für "fließenden" Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an. Mit Adobe-DRM wird hier ein "harter" Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.

Bitte beachten Sie bei der Verwendung der Lese-Software Adobe Digital Editions: wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!

Weitere Informationen finden Sie in unserer E-Book Hilfe.


Download (sofort verfügbar)

133,99 €
inkl. 7% MwSt.
Download / Einzel-Lizenz
ePUB mit Adobe-DRM
siehe Systemvoraussetzungen
E-Book bestellen